Global Patient-Derived Xenograft/PDX Model Market Set to Expand with Growing Emphasis on Personalized Medicine and Cancer Research
30. Januar 2024 05:20 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mice, Rat), Implantation Method (Subcutaneous, Orthotopic), Tumor Type (Respiratory,...
Pharmacokinetics Services Market Report 2023: A Global $1.75+ Billion Industry by 2030 - Analysis by Drug Type (Small Molecules) & End-use (Biotechnology & Pharmaceutical Companies)
14. November 2023 03:13 ET
|
Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use...
Early Toxicity Testing Global Market Report 2023: Growth in Prevalence of Chronic Diseases and Need for New Treatments Fuels Sector
17. Mai 2023 04:28 ET
|
Research and Markets
Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Early Toxicity Testing Market by Technique, by Toxicity Endpoint, by End User - Global Opportunity Analysis and Industry Forecast, 2023-2030" report has...
Asia-Pacific Pharmaceutical Industry Outlook Report 2023-2027: Top Predictions, Key Trends, Macroeconomic Factors, Revenues, Country-specific Trends, Opportunities
20. April 2023 09:18 ET
|
Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Industry Outlook 2023" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical market...
Global Contract Research Organization (CRO) Market Analysis Report 2022: Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth
14. Dezember 2022 04:18 ET
|
Research and Markets
Dublin, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The "Global Contract Research Organization (CRO) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The COVID-19 pandemic...
Global Pharma ADMET Testing Markets, 2022-2028: Advent of High-Throughput Screening & Opportunities in Automation and Advancements in ADME Testing
05. September 2022 06:33 ET
|
Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Pharma ADMET Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Testing Type, Technology, and Application" report has been added...
Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio Updates
08. Oktober 2020 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Company is restructuring with the goal of extending cash runway to mid-2022Workforce to be reduced by 54%Company to focus on completing Phase 3 dermatomyositis study and advancing preclinical pipeline...
OnCore Biopharma Licenses Second-Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection
09. September 2014 03:00 ET
|
OnCore Biopharma, Inc.
OnCore Secures Exclusive Worldwide Rights to NVP018
NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV
DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...